The effect of misoprostol with and without letrozole in inducing successful medical abortion

Document Type : Original Article

Authors

1 Assistant Professor, Department of Obstetrics and Gynecology, Clinical Research Development Center, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

2 General Practitioner, Clinical Research Development Center, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

3 Gynecologist, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

4 Radiologist, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

Abstract

Introduction: The pharmacological approach of abortion is a safe and effective alternative to surgical procedures that is associated with a high level of patient's satisfaction. The present study was performed with aim to evaluate the effect of misoprostol with and without letrozole in the treatment of successful medical abortion and its relationship with BHCG titration level and cervical length.
Methods: This two-group randomized clinical trial study was performed in 2021 on 168 pregnant women under 18 weeks of gestation who were candidates for termination of pregnancy. The patients were randomly divided into two groups: A (misoprostol and letrozole) and B (misoprostol and placebo). Initial tests, βHCG titration, ultrasound and cervical length were performed for all patients on the first day of hospitalization. After receiving the drug, all patients underwent ultrasound on the fifth day to evaluate complete abortion and removal of pregnancy residues. Data were analyzed by SPSS software (version 22) and Chi-square, independent t and logistic regression tests. P<0.05 was considered statistically significant.
Results: The results showed that misoprostol + letrozole had a more successful abortion rate than misoprostol + placebo (88.1% vs. 59.5%). Increased cervical length was associated with a higher probability of miscarriage (P <0.001), while BHCG titration did not show a predictive role in induction of abortion (p>0.05).
Conclusion: Adding letrozole to misoprostol for inducing abortion leads to an increase in the percentage of successful abortion and a reduction in the use of curettage.

Keywords

References

  1. Grimes DA, Stuart G. Abortion jabberwocky: the need for better terminology. Contraception 2010; 81(2):93-6.
  2. Bell SO, Shankar M, Moreau C. Global Epidemiology of Induced Abortion. InOxford Research Encyclopedia of Global Public Health; 2021.
  3. Javanmanesh F, Kashanian M, Mirpang S. Comparison of Using Misoprostol with or without Letrozole in Abortion Induction: A Placebo-Controlled Clinical Trial. Journal of Obstetrics, Gynecology and Cancer Research (JOGCR) 2018; 3(2):49-52.
  4. Shah I, Åhman E. Unsafe abortion: global and regional incidence, trends, consequences, and challenges. Journal of Obstetrics and Gynaecology Canada 2009; 31(12):1149-58.
  5. Naghshineh E, Allame Z, Farhat F. The effectiveness of using misoprostol with and without letrozole for successful medical abortion: A randomized placebo-controlled clinical trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 2015; 20(6):585.
  6. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. New England Journal of Medicine 2005; 353(8):761-9.
  7. Wu HL, Marwah S, Wang P, Wang QM, Chen XW. Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis. Scientific reports 2017; 7(1):1-9.
  8. Grønlund A, Grønlund L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Management of missed abortion: comparison of medical treatment with either mifepristone+ misoprostol or misoprostol alone with surgical evacuation. A multi‐center trial in Copenhagen county, Denmark. Acta obstetricia et gynecologica Scandinavica 2002; 81(11):1060-5.
  9. Petrou S, Trinder J, Brocklehurst P, Smith L. Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: an international journal of obstetrics & gynaecology 2006; 113(8):879-89.
  10. Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane database of systematic reviews 2004(1).
  11. Chen MJ, Creinin MD. Mifepristone with buccal misoprostol for medical abortion: a systematic review. Obstetrics & Gynecology 2015; 126(1):12-21.
  12. Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid‐trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2011(1).
  13. Wood SL, Brain PH. Medical management of missed abortion: a randomized clinical trial. Obstetrics & Gynecology 2002; 99(4):563-6.
  14. Allameh Z, Goharian M, Eslamian M. Effect of misoprostol with and without letrozole on the induction of abortion for women with first‐trimester missed abortion. International Journal of Gynecology & Obstetrics 2020; 151(2):214-8.
  15. Lee VC, Ng EH, Yeung WS, Ho PC. Misoprostol with or without letrozole pretreatment for termination of pregnancy: a randomized controlled trial. Obstetrics & Gynecology 2011; 117(2):317-23.
  16. Behroozi-Lak T, Derakhshan-Aydenloo S, Broomand F. Evaluation of effect of letrozole prior to misoprostol in comparison with misoprostol alone in success rate of induced abortion. Journal of gynecology obstetrics and human reproduction 2018; 47(3):113-7.
  17. Teimoori B, Esmaeilpoor M, Ashkezari AK, Farzaneh F. Comparison of induction abortion in the first trimester using misoprostol alone and misoprostol with estrogen priming. blood vessels 2019; 7:8.
  18. Behnamfar F, Mahdian M, Rahimi F, Samimi M. Misoprostol Abortion: Ultrasonography versus Beta-hCG testing for verification of effectiveness. Pakistan Journal of Medical Sciences 2013; 29(6):1367.
  19. Wong KS, Ngai CS, Yeo EL, Tang LC, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Human Reproduction 2000; 15(3):709-12.
  20. Bhattacharjee N, Saha SP, Ganguly RP, Patra KK, Jha T, Barui G, et al. A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination. Archives of gynecology and obstetrics 2012; 285(2):311-6.
  21. Torky HA, Marie H, ElDesouky E, Gebreel S, Raslan O, Moussa AA, et al. Letrozole vs. placebo pretreatment in the medical management of first trimester missed miscarriage: a randomized controlled trial. Geburtshilfe und Frauenheilkunde 2018; 78(01):63-9.
  22. Abbasalizadeh F, Sahhaf F, Sadeghi-Shabestari P, Mirza-Aghazadeh-Attari M, Naghavi-Behzad M. Comparison between effect of letrozole plus misoprostol and misoprostol alone in terminating non-viable first trimester pregnancies: a single blind randomized trial. Journal of family & reproductive health 2018; 12(1):27.
  23. Moreno JJ. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis. European Journal of Pharmacology 2017; 796:7-19.
  24. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. International journal of women's health 2011; 3:25.
  25. Kallner HK, Ho PC, Gemzell-Danielsson K. Effect of letrozole on uterine tonus and contractility: a randomized controlled trial. Contraception 2012; 86(4):419-24.
  26. Rezai Z, Heydari Bazardehi SS, Ghasemi Nezhad A, Saeid Sadeghi A, Ghorbani Yekta B. Letrozole and misoprostol versus misoprostol alone for termination of pregnancy: a randomized clinical trial. Tehran University Medical Journal. 2014;71(11).
  27. Yazdani S, Zeinalzadeh M, Bouzari Z. Investigating the comparative effect of combined regimens of letrozole with misoprostol alone for first trimester medical abortion. Caspian Journal of Reproductive Medicine. 2018;4(2):17-22.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 25, Issue 11
January 2023
Pages 8-15

Files

Share

How to cite

Statistics